Magalys Molina Jimenez, is a
Behavior Analyst based in Miami, Florida. Magalys Molina Jimenez is licensed to practice in Florida (license number 1-23-67814) and her current practice location is
10725 Sw 155th Ter, Miami, Florida. She can be reached at her office (for appointments etc.) via phone at
(786) 608-8113.
NPI number for Magalys Molina Jimenez is 1194501866 and her current mailing address is 10725 Sw 155th Ter, Miami, Florida. She
does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1194501866.
Provider's Profile
Full Name | Magalys Molina Jimenez |
---|
Gender | Female |
---|
Speciality | Behavior Analyst |
---|
Location | 10725 Sw 155th Ter, Miami, Florida |
---|
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
NPI Data:
- NPI Number: 1194501866
- Provider Enumeration Date: 09/07/2023
- Last Update Date: 06/09/2025
Medical Identifiers
Medical identifiers for Magalys Molina Jimenez such as npi, medicare ID, medicare PIN, medicaid, etc.
Identifier | Type | State | Issuer |
1194501866 | NPI | - | NPPES |
Medical Taxonomies and Licenses
Taxonomy | Type | License (State) | Status |
363LP0808X | Nurse Practitioner - Psychiatric/mental Health | 11040060 (Florida) | Secondary |
103K00000X | Behavior Analyst | 1-23-67814 (Florida) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Magalys Molina Jimenez is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
Mailing Address | Practice Location Address |
Magalys Molina Jimenez, 10725 Sw 155th Ter, Miami, FL 33157-1338 Ph: (786) 608-8113 | Magalys Molina Jimenez, 10725 Sw 155th Ter, Miami, FL 33157-1338 Ph: (786) 608-8113 |
Reviews and Comments